^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    tesetaxel (DJ 927)

    i
    Company:
    Daiichi Sankyo, Odonate Therap
    Drug class:
    Tubulin inhibitor
    Related drugs:
    Apply
    Phase II Study of Tesetaxel in Metastatic Melanoma (NCT01064713)
    Phase 2
    M.D. Anderson Cancer Center
    Completed
    Last update posted :
    07/17/2018
    Initiation :
    02/01/2010
    Primary completion :
    10/01/2014
    Completion :
    10/01/2014
    IL2
    |
    tesetaxel (DJ 927)